͵͵

Journal News

Understanding the fat science

Arti Dumbrepatil
April 9, 2024

Fat cells play a vital role in the storage and release of energy throughout the human body. When we are fasting, exercising or exposed to cold, our white adipose tissue, or WAT, generates energy through lipolysis, a process that breaks down lipids.

When lipids from WAT mobilize to the liver, triglycerides can accumulate, an underlying cause of , or NAFLD — a disease that affects about 100 million people in the U.S. and about 25% of the world's population.

The key questions are: How do the fatty acids released from WAT contribute to the liver lipid pool? And do exogenous fatty acids affect the liver?

Researchers at the University of California, Los Angeles, set out to understand lipid remodeling in the liver. The team led by Claudio Villanueva developed a targeted quantitative liquid chromatography–mass spectrometry method to study time-dependent changes in serum and liver lipids in response to lipolysis. Their was published in the Journal of Lipid Research.

“Our research highlights what are some of the lipids that are released by fat cells, in conditions such as fasting,” Villanueva said. “Fasting activates lipolysis, a process in which lipids are broken down into free fatty acids, which get mobilized to the liver through the bloodstream. The liver changes the amount of lipids based on what the fat cell is releasing, resulting in the accumulation of triacylglycerol or triglycerides. Accumulation of triglycerides leads to conditions like NAFLD.”

Researchers don’t completely understand the specific contribution of adipose-derived fatty acids to liver lipidome, but studies suggest these make up 70% of the triglyceride pool in the human liver. The method developed by the authors monitors serum and liver lipid levels after stimulating adipocyte lipolysis. To identify the different lipid species, the team collaborated with .

They demonstrated that the lipids from adipose tissue, directly and indirectly, remodel the liver lipids, which helped them understand lipid signaling. Lipid signaling drives regulation of lipid metabolism in the liver and the genes involved in lipid remodeling.

“We show how dynamic changes in fatty acids impact other lipid classes like ceramides and a variety of phospholipid species,” Villanueva said. “And using mice lacking adipose triglyceride lipase allowed us to examine how signals from adipose tissue impact lipid remodeling in the liver.”

Activation of adipocyte lipolysis led to a dramatic rise in serum lipids, mostly fatty acids, and ceramide species. Further, triglyceride pool in serum and liver analysis showed that linoleate is abundant. Linoleic acid is an essential polyunsaturated fatty acid that is a precursor for prostaglandins, leukotrienes and thromboxane. The results suggest that hepatocytes spare the use of linoleic acid for synthesis of these potent signaling molecules and store linoleic acid in molecular species such as triglycerides. preventing it from being used for fatty acid oxidation.

“This remodeling of the liver is a mechanism of providing energy for the body,” Villanueva said. “We have a ton of energy stored in our fat cells, and we need to move that energy to the liver so that the liver can metabolize it. The liver generates metabolites like ketone bodies, used by the brain to fuel neuronal function. The liver plays an important role when we go from feeding to the fasting state because it breaks down fats and provides fuel for the brain.”

Moving forward, the research team aims to understand what drives the transcriptional changes in the liver after activation of lipolysis in the fat cell.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Arti Dumbrepatil

is a freelance science writer and communicator. With her academic training plus expertise in science communication and writing, she demystifies and transforms complex, jargon-filled science into enjoyable and comprehensible content that resonates with a diverse audience. She is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.

From the journals: JLR
Journal News

From the journals: JLR

Nov. 15, 2024

Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.